Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

AGY Therapeutics

270 East Grand Avenue
South San Francisco, CA 94080
Website Company Summary Management Team

Management: Larry Powe (VP Clinical Development);  William Glennon (VP Finance/Treasurer);  Tamara Kent (Director of HR)
Outside board: Tamas Bartfai (Scripps Research Institute);  Frank Bulens (GIMV Venture Capital);  Elizabeth Czerepak (Bear Stearns Health Innoventures);  Jean Deleage (Alta Partners);  Hanns Mohler (Swiss Federal Institute of Technology);  William D Young (Monogram Biosciences CEO)

Business description: AGY Therapeutics, is dedicated to discovering and developing novel treatments for central nervous system (CNS) diseases, including stroke, Alzheimer's disease, depression, brain tumors and obesity. AGY Therapeutics is establishing a strong proprietary position for a large number of novel pharmaceutical agents, diagnostics and technologies. In its short history, the company has built a proprietary technology platform for functional gene discovery and for delineating specific mechanistic pathways underlying central nervous system diseases. AGY Therapeutics specializes in using animal models and tissue culture models to analyze the mechanistic pathways of disease progression. The company employs sequential molecular snapshots at multiple timepoints through the course of disease. This analysis results in understanding the location and expression of genes involved in the pathological process. Through this approach, AGY Therapeutics intends to identify optimal drug targets that can be used to develop therapeutic agents, as well as identify critical treatment time windows in which further central nervous system deterioration can be inhibited or tissue regeneration can occur.

Rounds: 3
Recent fundings: Apr 2004   Jul 2002
Capital raised: 68.0M
Last Round: 9.0M
Ownership: Private  
VCs include: Alta PartnersForward VenturesGIMVHBM BioventuresIcon VenturesMedicus Venture PartnersNIF VenturesNovartis Venture Fund;  Bear Stearns Innoventures;  Cheng Xin Venture Capital;  Lombard Odier;  Lotus Bioscience Ventures;  MIC Capital;  RAS Partners

Last Tweets


Last Mentions

Record updated: Apr 2005
Sector: Biotech
Year Founded: 1998
Rounds: 3
Recent fundings: Apr 2004   Jul 2002
Capital raised: 68.0M
Last Round: 9.0M
Ownership: Private